Acquiring Company
Pfizer
Description
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
- Pfizer To Acquire Reviral And Its Respiratory Syncytial Virus Therapeutic Candidates (April 7, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
- Abbvie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio (March 1, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.